Background: Starting HAART in a very advanced stage of disease is assumed to be the most prevalent form of initiation in HIV-infected subjects in developing countries. Data from Latin America and the Caribbean is still lacking. Our main objective was to determine the frequency, risk factors and trends in time for being late HAART initiator (LHI) in this region. Methodology: Cross-sectional analysis from 9817 HIV-infected treatment-naïve patients initiating HAART at 6 sites (Argentina, Chile, Haiti, Honduras, Peru and Mexico) from October 1999 to July 2010. LHI had CD4+ count ≤200cells/mm3 prior to HAART. Late testers (LT) were those LHI who initiated HAART within 6 months of HIV diagnosis. Late presenters (LP) initiated after 6 months of di...
OBJECTIVES: To investigate delayed HIV diagnosis and late initiation of antiretroviral therapy (ART)...
Introduction. Highly active antiretroviral therapy has been available since 1996. Early initiation o...
Objective: To report emerging data on the use of highly active antiretroviral therapy (HAART)in Arge...
Starting HAART in a very advanced stage of disease is assumed to be the most prevalent form of initi...
Background: Starting HAART in a very advanced stage of disease is assumed to be the most prevalent f...
Background: HAART rollout in Latin America and the Caribbean has increased from approximately 210,00...
BACKGROUND:Since 2009, earlier initiation of highly active antiretroviral therapy (HAART) after an o...
HAART rollout in Latin America and the Caribbean has increased from approximately 210,000 in 2003 to...
Introduction: Although antiretroviral therapy (ART) has been rapidly scaled up in Asia, most HIV-pos...
Background The benefits of antiretroviral therapy (ART) underpin the recommendations for the early d...
In Latin America, the first wave of HIV-infected patients initiated highly active antiretroviral the...
Many HIV-infected individuals do not enter health care until late in the infection course. Despite e...
Background: To ascertain the population rates and proportion of late entry into HIV care, as well as...
Background In Latin America, the first wave of HIV-infected patients initiated highly active antir...
OBJECTIVES: To investigate delayed HIV diagnosis and late initiation of antiretroviral therapy (ART)...
OBJECTIVES: To investigate delayed HIV diagnosis and late initiation of antiretroviral therapy (ART)...
Introduction. Highly active antiretroviral therapy has been available since 1996. Early initiation o...
Objective: To report emerging data on the use of highly active antiretroviral therapy (HAART)in Arge...
Starting HAART in a very advanced stage of disease is assumed to be the most prevalent form of initi...
Background: Starting HAART in a very advanced stage of disease is assumed to be the most prevalent f...
Background: HAART rollout in Latin America and the Caribbean has increased from approximately 210,00...
BACKGROUND:Since 2009, earlier initiation of highly active antiretroviral therapy (HAART) after an o...
HAART rollout in Latin America and the Caribbean has increased from approximately 210,000 in 2003 to...
Introduction: Although antiretroviral therapy (ART) has been rapidly scaled up in Asia, most HIV-pos...
Background The benefits of antiretroviral therapy (ART) underpin the recommendations for the early d...
In Latin America, the first wave of HIV-infected patients initiated highly active antiretroviral the...
Many HIV-infected individuals do not enter health care until late in the infection course. Despite e...
Background: To ascertain the population rates and proportion of late entry into HIV care, as well as...
Background In Latin America, the first wave of HIV-infected patients initiated highly active antir...
OBJECTIVES: To investigate delayed HIV diagnosis and late initiation of antiretroviral therapy (ART)...
OBJECTIVES: To investigate delayed HIV diagnosis and late initiation of antiretroviral therapy (ART)...
Introduction. Highly active antiretroviral therapy has been available since 1996. Early initiation o...
Objective: To report emerging data on the use of highly active antiretroviral therapy (HAART)in Arge...